Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks
Phase 3
18 Years
N/A
18 Years
N/A
Not Enrolling
Male
Prostate Cancer
Male
Prostate Cancer
Trial Information
Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks
Inclusion Criteria:
- Biopsy-proven diagnosis of prostate cancer, T1 or T2 of any risk level
- Biopsy done at enrolling site
- Upcoming appointment with consulting specialist at enrolling study site
- Able to read, write, understand English
Exclusion Criteria:
- Two or more post-biopsy specialist consults
- Begun treatment (or active surveillance)
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
Outcome Measure:
Decisional conflict
Outcome Description:
O'Connor, 1995, Decisional conflict scale
Outcome Time Frame:
Change from baseline to 6-months
Safety Issue:
No
Authority:
United States: Federal Government
Study ID:
12-363
NCT ID:
NCT01844999
Start Date:
July 2013
Completion Date:
August 2016
Related Keywords:
- Prostate Cancer
- Prostate cancer
- Decision
- Prostatic Neoplasms
Name | Location |
|---|
